Authors
Latest:
Smartphone direct ophthalmoscope tech helps visualise optic discA smartphone direct ophthalmoscope attachment makes it possible to examine the optic nerve and distinguish whether its state of health is normal or abnormal.
Latest:
Why the future of glaucoma care is in the operating roomSmaller surgeries, in greater numbers, await new glaucoma specialists
Latest:
Impact of Durable Therapies on Patients and Clinics and Monitoring StrategiesPanelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.
Latest:
Insights into neovascular glaucoma: Pathogenesis and detection of diabetic retinopathyManagement of neovascular glaucoma focuses on decreasing retinal ischemia through panretinal photocoagulation and the injection of anti-VEGF agents
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
An alternative approach to spectacle independenceLaser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs
Latest:
Cosmetic surgery of the cornea: A new type of surgeryA colourful look at how the keratopigmentation technique offers therapeutic and cosmetic applications.
Latest:
Book excerpt: Rescuing failed penetrating keratoplasty graftsPenetrating keratoplasty remains a popular choice for certain patients
Latest:
Not just for eating: Grapes and potatoes help surgery trainees hone skillsThe pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.
Latest:
New shape for an old device: A punctal plug that better fits into the punctumLarger 0.6-mm temporary plug features a tapered edge
Latest:
Rethinking dry eye disease with acute steroid treatmentLoteprednol etabonate suspension 0.25% demonstrates anti-inflammatory action and produces significant improvement in conjunctival hyperaemia and ocular discomfort.
Latest:
Not just for eating: Grapes and potatoes help surgery trainees hone skillsThe pandemic has impacted ophthalmic surgical training. Exercises have been developed to provide key skills that can be practised simply at home and require no special equipment.
Latest:
A new home treatment for amblyopiaBinocular eye tracking could serve as alternative to patching and provide visual acuity gains with heightened adherence rates
Latest:
Extended dosing with faricimab = greater fluid control compared with aflibercept for DMEFaricimab could lower treatment burden for patients compared to aflibercept
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Focusing on laser trabeculoplasty, the glaucoma workhorseDebate continues over the best way to apply treatment option
Latest:
The ZEISS IOL Power Calculation Service. Providing guidance in complex casesAdvances in biometric technology and IOL calculation formulas have enabled refractive accuracy of cataract and clear lens exchange (CLE) surgery, but IOL power selection remains challenging in some cases. I have found that the ZEISS IOL Power Calculation Service (IPCS) is a valuable asset to help me in these uncertain situations.
Latest:
Electronic health records: how the pandemic highlighted the future of practice managementElectronic health records may be the future of practice management.
Latest:
Impact of Disease Activity Criteria on Dosing Interval Assignment in Clinical Trials in nAMDDr Marco Zarbin presents his talk from the 2023 ASRS annual meeting, where he explores the impact of disease activity criteria on drug durability estimations in clinical trials and includes a comparative analysis across multiple clinical trials in neovascular AMD (age-related macular degeneration).
Latest:
Benefits of topography-guided treatments for irregular corneasTopography-guided treatments for irregular corneas can improve patients’ best corrected visual acuity. The technique is easy to plan and perform, supported by software to do the calculations.
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Putting diagnostic accuracy to the testA confirmed diagnosis of familial exudative vitreoretinopathy aids in several aspects of patient management
Latest:
Removing opioid prescriptions from cataract surgeryDrug delivery solutions to manage pain after cataract surgery improves adherence.
Latest:
Understanding the genetics of glaucomaMany genes and polymorphisms have been identified as being associated with glaucoma, predicting progression, identifying those at increased risk and allowing treatment to be optimised.
Latest:
Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditionsClinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Latest:
ARVO 2024: Novel contact lens solution bolsters comfort in potential lens wear dropoutsMarjorie Rah, OD, PhD, FAAO, discussed the in-home use test of BioTrue Hydration Plus multipurpose contact lens solution (Bausch + Lomb) on patients who are considering lens dropout.
Latest:
Leveraging UVC light for infection prevention in ophthalmology and beyondThe threshold limit value is increased for virus and bacterial eradication.
Latest:
Minimising risks during routine ophthalmic examinations in the COVID-19 eraUntil we have a vaccine and see a reduction of COVID-19 cases down to zero, we must adjust and take every precaution possibly to protect our staff, as well as our patients.
Latest:
Glaucoma specialists take back treatment complianceMoving on from medication “stacks” and the old-school reactive approach
